Back
abrdn Bloomberg All Commodity Strat K-1 Free ETF Vs. Novo Nordisk AS Industry Stock Comparison
Sell
7
BCI
abrdn Bloomberg All Commodity Strat K-1 Free ETF
Last Price:
$19.57
Seasonality Move:
-2.38%
Sell
26
NVO
Novo Nordisk AS
Last Price:
$87.42
Seasonality Move:
6.58%
Sell
7
abrdn Bloomberg All Commodity Strat K-1 Free ETF (BCI)
is a Sell
Is abrdn Bloomberg All Commodity Strat K-1 Free ETF a Buy, Sell or Hold?
-
The current abrdn Bloomberg All Commodity Strat K-1 Free ETF [BCI] share price is $19.44. The Score for BCI is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.
-
BCI is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
26
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NVO] share price is $88.71. The Score for NVO is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BCI Stock Price Chart
What is abrdn Bloomberg All Commodity Strat K-1 Free ETF's stock price today?
-
The abrdn Bloomberg All Commodity Strat K-1 Free ETF share price today is $19.44Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCI is experiencing buying pressure, which is a positive indicator for future bullish movement.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $88.71Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing buying pressure, which is a positive indicator for future bullish movement.
BCI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 31.69 | Sell |
Chaikin Money Flow: | 890879 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (19.87 - 20.33) | Sell |
Bollinger Bands (100): | (19.48 - 20.42) | Sell |
NVO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.52 | Sell |
Relative Strength Index (14 RSI): | 27.28 | Sell |
Chaikin Money Flow: | 14079249 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (99.16 - 111.42) | Sell |
Bollinger Bands (100): | (106.53 - 131.27) | Sell |
BCI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 20.14 | Sell |
20-day SMA: | 20.14 | Sell |
50-day SMA: | 20.17 | Sell |
200-day SMA: | 20.13 | Sell |
8-day EMA: | 19.99 | Sell |
20-day EMA: | 20.09 | Sell |
50-day EMA: | 20.11 | Sell |
200-day EMA: | 20.15 | Sell |
NVO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 101.84 | Sell |
20-day SMA: | 105.84 | Sell |
50-day SMA: | 108.65 | Sell |
200-day SMA: | 126.03 | Sell |
8-day EMA: | 99.1 | Sell |
20-day EMA: | 103.93 | Sell |
50-day EMA: | 109.19 | Sell |
200-day EMA: | 117.8 | Sell |
abrdn Bloomberg All Commodity Strat K-1 Free ETF Earnings Growth & BCI Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.66 per share.
abrdn Bloomberg All Commodity Strat K-1 Free ETF Technical Analysis
Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |